Global Electrosurgical Devices Market Overview:
The electrosurgical devices market is expected to grow in the future due to a growing demand for minimally invasive surgeries and increasing adoption of technologically advanced products. Electrosurgery is a term used to describe multiple modalities that use electricity to cause thermal destruction of tissue through dehydration, coagulation, or vaporization. Electrosurgical devices find many applications such as general surgery, cardiology, urology, gynecology, cosmetology, and dermatology domains.
Growth Drivers
- Rise in Number of Surgical Procedures Globally
- Increasing Geriatric Population
- Rising Prevalence of Chronic Diseases
Market Trends
- Technological Advancement in Electrosurgical Device
Roadblocks
- High Cost Associated with Surgical Devices
Opportunities
- High Market Potential in Untapped Emerging Economies Huge Investments by Major Players
- Growth in the Health Care Industry
Challenges
- Stringent Government Regulations for Electrosurgical Device Approval
Competitive Landscape:
Key players are implementing various strategies such as mergers & acquisitions, new product development, joint ventures, partnerships and others. Medical technology and healthcare companies are setting standards by manufacturing surgical instruments with the help of various technological advancements.
Some of the key players profiled in the report are B. Braun Melsungen (Germany), Bovie Medical (United States), Megadyne Medical Products (United States), CONMED (United States), Medtronic (Ireland), Johnsons & Johnsons (United States), ERBE Elektromedizin (Germany), KLS Martin (Germany), Olympus (Japan) and Utah Medical Products (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Electrosurgical Devices market by 2026. Considering Market by Method, the sub-segment i.e. Monopolar will boost the Electrosurgical Devices market. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Electrosurgical Devices market.
In July 2020, Lexington Medical and BOWA Medical, a leading innovator of energy based surgery products for medical applications, have entered into a commercial agreement.Under the partnership, the companies will jointly market and sell the AEON™ and LOTUS™ portfolios in several global markets., and In Sept 2019, Gala Therapeutics, Inc. announced that its RheOx™ system has received CE Mark in the European Union. In a minimally invasive procedure called Bronchial Rheoplasty™, RheOx delivers non-thermal energy to the airways to reduce mucus-producing cells in patients with Chronic Bronchitis.
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Electrosurgical Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Electrosurgical Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Electrosurgery Devises Manufactures, Electrosurgery DevisesSuppliers, Electrosurgery Devises Distributors, Government Regulatory Bodies, Government Research Organizations, Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.